Natural supplement trial offers hope for rare immune disorder lung damage
Disease control
ENROLLING_BY_INVITATION
This study is testing whether a supplement called Fisetin can help treat lung scarring in people with common variable immunodeficiency (CVID), a rare immune system disorder. Twenty participants will receive either Fisetin or a placebo to see if it improves lung function, reduces …
Phase: PHASE2 • Sponsor: Avni Joshi • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC